$NAMS
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
Healthcare
Sector
Biotechnology
Industry
Michael Harvey Davidson Facp.
CEO
68
Employees
$23.20
Current Price
$3.93B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $1,257,657.38 | 50,246 | ||
| 2 months | Buys | 1 | 1 | $226,500.00 | 10,000 | 1:20.58 |
| Sells | 2 | 3 | $4,661,919.38 | 176,846 | ||
| 3 months | Buys | 1 | 1 | $226,500.00 | 10,000 | 1:20.58 |
| Sells | 2 | 3 | $4,661,919.38 | 176,846 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Kastelein Johannes Jacob Pieter Director | Sale | 50,246 | $25.03 | $1,257,657.38 | View Details |
| Sep 14, 2026 | Davidson Michael H. Director | Purchase | 10,000 | $22.65 | $226,500.00 | View Details |
| Sep 4, 2026 | Smither John W Director | Sale | 1,600 | $25.32 | $40,512.00 | View Details |
| Aug 24, 2026 | Kastelein Johannes Jacob Pieter Director | Sale | 125,000 | $26.91 | $3,363,750.00 | View Details |
| Jul 20, 2026 | Kooij Louise Frederika Chief Accounting Officer | Sale | 70,200 | $29.96 | $2,103,192.00 | View Details |
| Jul 20, 2026 | Kooij Louise Frederika Chief Accounting Officer | Sale | 2,915 | $31.71 | $92,434.65 | View Details |
| Jul 20, 2026 | Kooij Louise Frederika Chief Accounting Officer | Sale | 31,885 | $31.05 | $990,029.25 | View Details |
36 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.49
ActualN/A
Revenue
Estimated$7.54M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: